BANK OF MONTREAL /CAN/ - OBALON THERAPEUTICS INC ownership

OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 1 filers reported holding OBALON THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of OBALON THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$0710.0%0.00%
Q1 2019$0
-100.0%
71
-87.4%
0.00%
Q4 2018$1,000
-50.0%
5620.0%0.00%
Q3 2018$2,000
+100.0%
5620.0%0.00%
Q2 2018$1,000
-75.0%
562
-54.5%
0.00%
Q1 2018$4,0001,235
+1639.4%
0.00%
Q4 2017$0
-100.0%
710.0%0.00%
Q3 2017$1,000710.00%
Other shareholders
OBALON THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 2,453,338$26,226,0005.58%
Tamarack Advisers, LP 565,912$6,050,0003.78%
LEVEL FOUR ADVISORY SERVICES, LLC 416,171$4,448,0000.45%
Moisand Fitzgerald Tamayo, LLC 9,362$358,0000.25%
FORMULA GROWTH LTD 108,998$1,165,0000.24%
TIVERTON ASSET MANAGEMENT LLC 148,600$1,589,0000.08%
KORNITZER CAPITAL MANAGEMENT INC /KS 420,335$4,493,0000.08%
Bellevue Group AG 40,000$428,0000.06%
Nicholas Investment Partners, LP 58,585$626,0000.04%
WASATCH ADVISORS LP 267,949$2,864,0000.04%
View complete list of OBALON THERAPEUTICS INC shareholders